Nexgel Inc (NXGL) Institutional Buying & Selling Tracker (Q2 2026)

NXGL ranks #8527 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

19 institutions disclose a position in NXGL, but none treat it as a major bet — even Ground Swell Capital, LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

UBS Group AG has added to its NXGL position for two straight quarters, increasing it by $12.4K to reach $12.4K today.

Morgan Stanley has trimmed its NXGL position for two straight quarters, cutting it by $110.0K while still holding $27.5K.

NXGL reported a net loss of $6.2M over the trailing twelve months.

• Not yet profitable — net loss of $6.2M over the trailing twelve months
• Revenue grew 3.4% year over year
• Net income declined year over year, from -$2.9M to -$6.2M
• Operating cash flow was negative, using $1.3M in cash
• Current ratio of 1.47x — below the conventional 1.5x liquidity buffer
• Liabilities run 696.25x equity — a highly leveraged balance sheet worth noting